Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis (Q36538190)
Jump to navigation
Jump to search
scientific article published on 19 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis |
scientific article published on 19 December 2011 |
Statements
1 reference
Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis (English)
1 reference
M S Freedman
1 reference
C Metzig
1 reference
L Kappos
1 reference
C H Polman
1 reference
G Edan
1 reference
H-P Hartung
1 reference
D H Miller
1 reference
X Montalban
1 reference
J Yarden
1 reference
L Spector
1 reference
E Fire
1 reference
N Dotan
1 reference
S Schwenke
1 reference
V Lanius
1 reference
R Sandbrink
1 reference
C Pohl
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference